Rare diseases
Investigational molecules
Locations
Back to Latvia7 clinical trials in Talsi, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
LatviaStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
LatviaStudy on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis
LatviaStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
LatviaStudy on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis
LatviaStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
LatviaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
LatviaThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on plaque psoriasis treatments are evaluating novel therapeutic approaches. Studies are examining both long-term safety and immediate efficacy of innovative medications for patients with moderate to severe conditions.
These investigations aim to expand treatment options for patients with challenging dermatological conditions.
Research initiatives are exploring treatments for atopic dermatitis, with particular attention to long-term therapeutic solutions. The studies include assessment of nemolizumab in both adult and adolescent populations.
These trials represent significant advancement in understanding chronic skin condition management.
Current clinical research is evaluating multiple treatment modalities for chronic skin conditions, including both oral medications and specialized therapies. Studies focus on measuring both immediate and sustained therapeutic responses.
Research aims to establish more effective and sustainable treatment options for patients with persistent skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
